Pramipexole is a dopamine agonist - it stimulates dopamine receptors directly rather than replacing dopamine as levodopa does. It is used in Parkinson's disease and in restless legs syndrome. It has two side effects that matter more than the ordinary list, because neither feels like a side effect to the person experiencing it: compulsive behaviours, and sudden onset of sleep. Both are under-recognised and both can be devastating.
Follow the plan your prescriber gave you. This guide contains no doses. Do not stop it suddenly.
Impulse control disorders
Dopamine agonists can cause compulsive behaviours - pathological gambling, compulsive shopping, binge eating, hypersexuality, and repetitive purposeless activity.
These are not character flaws and they are not coincidence. They are a recognised, dose-related effect of stimulating dopamine reward pathways, they affect a meaningful proportion of people on these drugs, and they usually resolve when the medicine is reduced or stopped.
The difficulty is that the person affected does not experience it as a medication side effect. Life savings are lost, relationships end, and nobody connects it to a tablet for restless legs. It is frequently a family member who notices first.
Anyone starting a dopamine agonist should be told about this, and so should the people they live with. If you have noticed new gambling, spending, eating or sexual behaviour since starting, report it - it is a medical problem with a medical solution, and there is no reason for embarrassment.
Prescribers are expected to ask about it at reviews. If nobody has, it is worth raising.
Sudden onset of sleep
Dopamine agonists can cause excessive daytime sleepiness and, in some people, sudden sleep attacks without warning - including while driving.
Episodes have occurred in people who reported no drowsiness beforehand, which is what makes this different from ordinary sedation.
You must inform the DVLA if you have excessive sleepiness, and you must not drive if you have had any episode of sudden sleep. Our guide to medicines and driving covers notification.
In Parkinson's disease
Pramipexole is used alone in earlier disease, or alongside levodopa later. Using a dopamine agonist first in younger patients delays some of the movement complications that develop with long-term levodopa.
It does not slow the disease. It treats the symptoms - stiffness, slowness and tremor.
Anti-sickness medicines that block dopamine will make Parkinson's worse and should be avoided - prochlorperazine and metoclopramide in particular. This is a common and avoidable error when someone with Parkinson's presents with nausea. See prochlorperazine and metoclopramide.
In restless legs syndrome
Pramipexole is effective for restless legs, but there is a specific long-term problem: augmentation.
Augmentation means the condition gets worse on treatment - symptoms start earlier in the day, become more intense, and spread to the arms. It is caused by the treatment, and the instinct to increase the dose makes it worse.
Because of this, guidance has moved away from dopamine agonists as first choice for restless legs, favouring alpha-2-delta ligands such as gabapentin or pregabalin - see pregabalin.
Check iron first. Low ferritin is a common and treatable cause of restless legs, and correcting it can remove the need for any of this - see iron tablets.
Other side effects
Nausea, dizziness on standing, constipation, headache and swollen ankles. Hallucinations and confusion occur, more often in older people and in more advanced Parkinson's.
The dose is built up slowly to limit nausea and dizziness.
Pramipexole is cleared by the kidneys, so the dose is reduced in impairment - see medicines that affect your kidneys.
Do not stop suddenly
Abrupt withdrawal can cause a dopamine agonist withdrawal syndrome - anxiety, panic, depression, sweating, pain and drug craving - which can be severe and prolonged.
In Parkinson's, sudden withdrawal also risks a serious deterioration. Any reduction is planned and gradual with your specialist.
Our guide to why you cannot just stop some medicines covers the principle, and running out counts as stopping - see ordering repeats.
Other dopamine agonists
Ropinirole and rotigotine work in the same way and carry the same risks - impulse control disorders and sudden sleep apply to the whole class, not to pramipexole alone.
Rotigotine comes as a daily patch, which suits people who struggle with swallowing or who need steady levels overnight - see how to use and rotate patches. Switching between agonists does not remove the class effects, so the warnings above still apply after a change.
Modified-release forms
A once-daily modified-release version exists. It must be swallowed whole - see cutting and crushing tablets - and the immediate-release and modified-release forms are not interchangeable tablet for tablet.
Oxybutynin: What It Does for an Overactive Bladder covers a related point, and the Conditions section has the rest of these guides.